Chiome Bioscience
4583.TTSE GROWTHPharmaceutical
Major holders (5%+) · 0
| Holder | Stake |
|---|
No holder currently reports 5% or more.
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 5
| Barclays Bank PLC | 4.30% |
| Growth Capital Inc. | 4.06% |
| Next Growth Inc. | 1.66% |
| Barclays Capital Securities Ltd. | 0.50% |
| Barclays Securities Japan Limited | 0.00% |
Ownership history · 47
| Holder | Ratio | Change |
|---|---|---|
| Growth Capital Inc.2025-12-22 · amended | 4.06% | -1.09pp |
| Growth Capital Inc.2025-12-22 · amended | 5.15% | -1.08pp |
| Growth Capital Inc.2025-12-22 · amended | 6.23% | -1.06pp |
| Growth Capital Inc.2025-12-22 · amended | 7.29% | -1.22pp |
| Growth Capital Inc.2025-12-22 · amended | 8.51% | -1.06pp |
| Growth Capital Inc.2025-12-22 · amended | 9.57% | -1.08pp |
| Growth Capital Inc.2025-12-22 · amended | 10.65% | -0.71pp |
| Growth Capital Inc.2025-12-22 · amended | 11.36% | -1.00pp |
| Growth Capital Inc.2025-12-22 · amended | 12.36% | -0.83pp |
| Growth Capital Inc.2025-12-22 · amended | 13.19% | -1.10pp |
| Growth Capital Inc.2025-12-22 · amended | 14.29% | -0.74pp |
| Growth Capital Inc.2025-12-22 · amended | 15.03% | -1.15pp |
| Growth Capital Inc.2025-12-22 · amended | 16.18% | +13.39pp |
| Next Growth Inc.2024-07-24 · amended | 1.66% | -0.01pp |
| Growth Capital Inc.2024-07-24 · amended | 2.79% | -1.18pp |
| Next Growth Inc.2024-07-24 · amended | 1.67% | -0.01pp |
| Growth Capital Inc.2024-07-24 · amended | 3.97% | -1.30pp |
| Next Growth Inc.2024-07-24 · amended | 1.68% | -0.01pp |
| Growth Capital Inc.2024-07-24 · amended | 5.27% | -1.12pp |
| Next Growth Inc.2024-07-24 · amended | 1.69% | -0.03pp |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.